Algae grown on dairy effluent cuts mineral fertiliser use by 25%
ADVERTISEMENT
ADVERTISEMENT
More about this topic
Cause of death for Buffy actress Michelle Trachtenberg revealed
NYC medical examiner has said the 39-year-old actress died as a result of complications from diabetes.
1 in 5 UK adults estimated to have diabetes in new record high
More than 1 million adults in the UK have type 2 diabetes but have not been diagnosed, according to the newly-released report.
Eli Lilly shares rise as Zepbound weight-loss test shows solid success
Lilly said patients taking Zepbound lost about 20% of their weight on average compared with nearly 14% for Wegovy. The drug maker also said more patients taking Zepbound achieved at least 25% weight loss.
Over 800 million people have diabetes globally. What about in Europe?
Diabetes rates have doubled globally in the last three decades, a new study suggests, here’s what to know about the situation in Europe.
ADVERTISEMENT
Weight-loss drugs like Ozempic may reduce opioid overdose rates
A new study found a link between new popular GIP/GLP-1 receptor agonists and a reduced rate of overdose or intoxication in people with opioid and alcohol use disorders.
Intense weekend exercise may have similar benefits to regular workouts
Both regular exercise and intense weekend exercise were found to lower the risk of more than 200 diseases, including hypertension and diabetes.
Novo Nordisk boss in US grilling over prices for weight-loss drugs
Novo Nordisk has been criticised by US politicians for the high pricing of its popular weight-loss and diabetes drugs. But CEO Lars Fruergaard Jørgensen has defended the company, attributing the elevated prices to "structural issues" within the US healthcare system.
Insulin resistance linked to risk of over 30 diseases and early death
A recent study found that insulin resistance is associated with an increased risk of 26 conditions, a lower risk of five more, and early death in women.
Novo Nordisk: Earnings trimmed as rivals seek to enter market
Novo Nordisk missed earnings expectations in the second quarter due to growing competition and increased costs from capacity expansions. The company also downgraded its profit outlook for 2024.
Diabetes-reversing treatment boosts insulin-producing cells by 700%
A new preclinical study found a combination treatment that significantly increases insulin-producing cells, effectively reversing diabetes.
Wegovy and Ozempic maker Novo Nordisk plans billion-dollar US plant
Novo Nordisk announces a plan to invest $4.1 billion to expand its capacity of making weight loss drug Wegovy and diabetes treatment Ozempic.
Intermittent fasting may help type 2 diabetics control blood sugar
A new study found that intermittent fasting may be an effective initial intervention for type 2 diabetics instead of medication.
Novo Nordisk beats Q1 estimates as weight-loss drugs drive growth
Danish pharmaceutical titan Novo Nordisk, the maker of Ozempic and Wegovy, announces a significant year-over-year increase in net profit and sales for the first quarter of 2024.
Oral insulin could replace injections for diabetics, new study finds
A new form of oral insulin, which may soon be tested in humans, can be taken as an alternative to syringes or insulin pumps.
Glucose monitors are gaining popularity among those without diabetes
This stick-on arm patch is among the new generation of glucose monitors.
Americans turn to alternatives amid Ozempic shortage
Approved in 2017 for adults with type 2 diabetes, Ozempic has now become a blockbuster weight loss drug.